Private Advisor Group, LLC Alterity Therapeutics LTD Transaction History

Private Advisor Group, LLC

  • $17.4 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 02, 2020
SELL
$0.0 - $0.05 $0 - $22
-449 Closed
0 $0
Q2 2020

Aug 17, 2020
BUY
$0.0 - $0.03 $0 - $13
449 New
449 $1,000

Others Institutions Holding ATHE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ALTERITY THERAPEUTICS LTD

ATHE Quotes by TradingView
  • Ticker ATHE
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,114,600
  • Market Cap $196M
  • Description
  • Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also...
More about ATHE
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email